The Fed's Silent Admission: Inflation Isn't Going Anywhere Soon

The Federal Reserve held rates steady this week, but the real story wasn't what Chair Jerome Powell said in prepared remarks. It was what the Fed's own staff projections revealed about inflation's staying power. The central bank's economists now expect price growth to hover above their 2% target through 2025, a significant shift from their summer forecast of faster disinflation. Nobody announced this shift with fanfare. Reporters had to read the footnotes in policy documents to find it.

This matters because the Fed spent two years telling Americans inflation would fade once supply chains normalized and energy prices stabilized. Both happened. Inflation still hasn't cooperated. Service-sector costs—everything from restaurant meals to haircuts to insurance premiums—refuse to cool. Wages rose faster than expected, workers demanded higher pay to match higher prices, and employers passed those costs along to consumers. The cycle perpetuates itself.

The practical consequence: households planning purchases should expect slower income growth than they might have assumed. A worker expecting a 3% raise next year will lose purchasing power if inflation runs at 2.8%. Savers benefit slightly from the Fed's "higher for longer" stance on rates, but borrowers face continued pressure on mortgages and credit card debt. Refinancing won't arrive as quickly as some hoped.

What happens next depends on whether the Fed miscalculated about service-sector inflation or whether the economy simply resists the traditional playbook. If inflation breaks lower without a recession, the Fed dodges criticism. If unemployment rises sharply to cool prices, Powell faces a different kind of pressure. The Fed's own projections show officials expect unemployment to edge up, suggesting they've already accepted some job losses as the price of price stability.

Watch for December retail sales data and January's jobs report. Those numbers will tell markets whether the economy's momentum has genuinely slowed or whether consumers are still spending with borrowed optimism. The Fed's patience depends on seeing concrete evidence that inflation will break.

Sleeper Story: A federal appeals court ruled this week that Medicare can negotiate drug prices, clearing a legal barrier that drugmakers had hoped would derail the policy. The decision doesn't get headlines like rate decisions do, but it affects medication costs for 65 million Americans starting in 2026. Pharmaceutical stocks dropped on the news, signaling that investors believe the ruling will stick.

Scoop's Kicker: The Fed admitted inflation won't die on schedule, but nobody's asking why the experts got it wrong in the first place.